Nicotinic attenuation of CNS inflammation and autoimmunity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9566273
SERIAL NO

14451318

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DIGNITY HEALTH3033 NORTH THIRD AVENUE PHOENIX AS 85013

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lukas, Ronald J Phoenix, US 7 8
Shi, Fu-Dong Scottsdale, US 4 3
Vollmer, Timothy Parker, US 8 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 14, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00